2014 SABCS Public Friday
Read More
`San Antonio, TX - SABCS 2014 San Antonio Breast Cancer Symposium - Hurvitz SA discusses "S6-01. Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1" during General Session 6 here today, Friday December 12, 2014. during the San Antonio Breast Cancer Symposium being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. Over 7,500 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Photo by © MedMeetingImages/Todd Buchanan 2014 Technical Questions: todd@medmeetingimages.com
